Good Cascade Impactor Practice (GCIP) and Considerations for “In-Use” Specifications

Documenti analoghi

• Good cascade impactor practices, AIM and EDA for orally inhaled products
  di: Tougas, Terrence P., et al.
  Pubblicazione: (2013.)
• The Effect of Nonideal Cascade Impactor Stage Collection Efficiency Curves on the Interpretation of the Size of Inhaler-Generated Aerosols
  di: Roberts, D. L., et al.
  Pubblicazione: (2013)
• Cascade Impactor (CI) Mensuration—An Assessment of the Accuracy and Precision of Commercially Available Optical Measurement Systems
  di: Chambers, Frank, et al.
  Pubblicazione: (2010)
• Effect of Sampling Volume on Dry Powder Inhaler (DPI)-Emitted Aerosol Aerodynamic Particle Size Distributions (APSDs) Measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen Eight-Stage Cascade Impactor (ACI)
  di: Mohammed, Hlack, et al.
  Pubblicazione: (2012)
• Internal Volumes of Pharmaceutical Compendial Induction Port, Next-Generation Impactor With and Without Its Pre-separator, and Several Configurations of the Andersen Cascade Impactor With and Without Pre-separator
  di: Roberts, Daryl L., et al.
  Pubblicazione: (2020)